Details for New Drug Application (NDA): 022549

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 022549 describes ADASUVE, which is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the ADASUVE profile page.

The generic ingredient in ADASUVE is loxapine. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loxapine profile page.

Summary for 022549

Tradename:	ADASUVE
Applicant:	Alexza Pharms
Ingredient:	loxapine
Patents:	7
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 022549

Antipsychotic Agents
Dopamine Antagonists

Suppliers and Packaging for NDA: 022549

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ADASUVE	loxapine	POWDER;INHALATION	022549	NDA	Alexza Pharmaceuticals, Inc.	51097-001	51097-001-02	5 INHALER in 1 CARTON (51097-001-02) / 1 AEROSOL, POWDER in 1 INHALER (51097-001-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	POWDER;INHALATION			Strength	10MG
Approval Date:	Dec 21, 2012	TE:		RLD:	Yes
Patent:	See Plans and Pricing	Patent Expiration:	May 20, 2022	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:	See Plans and Pricing	Patent Expiration:	Aug 18, 2024	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:	See Plans and Pricing	Patent Expiration:	Oct 28, 2024	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 022549

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alexza Pharms	ADASUVE	loxapine	POWDER;INHALATION	022549-001	Dec 21, 2012	See Plans and Pricing	See Plans and Pricing
Alexza Pharms	ADASUVE	loxapine	POWDER;INHALATION	022549-001	Dec 21, 2012	See Plans and Pricing	See Plans and Pricing
Alexza Pharms	ADASUVE	loxapine	POWDER;INHALATION	022549-001	Dec 21, 2012	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.